Newbridge and Temasek get 100 % return from Matrix

Singapore’s Temasek Holdings and Newbridge Capital, which together hold a combined 38 percent stake in India’s Matrix Laboratories, stand to make about 100 percent return on the pharmaceutical bet they made in May 2004.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this